The precision medicine software developers market is projected to grow at an annualized rate of 30%, till 2032, claims Roots Analysis Given their ability to cater to the existing unmet needs in the healthcare sector, various industry stakeholders have made investments for the development and implementation of precision medicine software applications for diagnosis, analysis and treatment of a range of disorders. Roots Analysis has announced the addition of “Precision Medicine Software Market 2021-2032” report to its list of offerings. Conventional methods being used for the treatment of various disease indications are fraught with several challenges, including inefficiency of reporting any medical symptom / condition at the initial stage, frequent visits to hospitals, the one-size-fits-all approach. These bottlenecks have encouraged healthcare professionals to shift their attention towards the use of precision medicine software applications. Key Market Insights Around 50% of software applications are intended for the treatment of oncological disorders Presently, several precision medicine software applications are intended for diagnosis, analysis and / or treatment of oncological disorders. Other popular therapeutic areas being targeted by such software applications include neurological disorders (13%) and cardiovascular disorders (11%). Patents filed related to precision medicine software applications, increased at a CAGR of 57% Of the total, around 80% of the patents were filed as applications, followed by granted patents. It is worth mentioning that most of the patents (55%) were filed / granted in North America. Further, 68% of the total active patents were filed in this region, during the period 2018-2021. Partnership activity has grown at an annualized rate of over 72%, between 2018 and 2020 Maximum number of partnerships were established in 2020, indicating the rising interest of stakeholders in this domain. Service agreements emerged as the most common type of partnership model adopted by players engaged in this domain, representing about 40% of the total number of instances. About USD 2.4 billion has been invested by both public and private investors in this field Funding activity in this domain has increased at a CAGR of 52%, during the period 2018-2020. Around 44% of the total amount invested was raised through venture funding rounds. In addition, majority of the funding instances (35) were focused on business development. To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/precision-medicine-software-developers-market/request-sample.html For additional details, please visit https://www.rootsanalysis.com/reports/precision-medicine-software-developers-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Cell Therapy Manufacturing Market, 2021-2030 3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/